Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Los términos de búsqueda han de ser en inglés.

Latvian research centre offering a molecular diagnostic test for breast cancer is looking for partners to conclude license agreement

Resumen

Tipo:
Oferta Tecnológica
Referencia:
TOLV20210805001
Publicado:
17/08/2021
Caducidad:
17/08/2022
Resumen:
A Latvian research centre that is engaged in the commercialization of its own scientific and technical developments is looking for partners for license agreements for one of its technologies. The company provides a set of molecular tests for breast cancer diagnosis that will help doctors make treatment decisions and monitor the progress of treatment.

Details

Tittle:
Latvian research centre offering a molecular diagnostic test for breast cancer is looking for partners to conclude license agreement
Summary:
A Latvian research centre that is engaged in the commercialization of its own scientific and technical developments is looking for partners for license agreements for one of its technologies.
The company provides a set of molecular tests for breast cancer diagnosis that will help doctors make treatment decisions and monitor the progress of treatment.
Description:
A long established Latvian research centre specialized in molecular biology and biomedicine has evolved into a powerful scientific centre performing basic as well as applied research in three major directions:
- molecular medicine and disease mechanisms;
- cancer research;
- structural biology, biotechnology and virusology.
The centre offers an innovative and unique personalized molecular diagnostic test for breast cancer for therapy selection and disease monitoring.
The test has been developed to deal with the problem in relation to chemotherapy that usually causes significant side effects. The mentioned set will help doctors to make appropriate treatment decisions and further monitor the progress of treatment. The set of tests consists of tumor profiling technology (somatic mutation technology) and a personalized ´liquid biopsy´ test.
The Centre is looking for partners for cooperation under license agreement- both SMEs and large enterprises - working in the field of medical examination and diagnostics that perform both laboratory services and cancer examination tests
Advantages and Innovations:
The advantages of the proposed technology are:
1. It´s non-invasive nature and the ability to provide comprehensive information on the most appropriate treatment options and response.
2. Precision diagnostics tool provides detailed tumor molecular profiling for effective and personalised treatment selection.
3. The acquired information is passed from one test to the next so that it can be used as effectively as possible.
4. Highest available accuracy.
5. Economic advantage.

Innovation of the test includes:
· A unique multigene panel targeting specific genes related to breast cancer.
· Technology designed with unique molecular identifiers (UMIs) that provide error correction and increased accuracy during sequencing.
· Test can be used both for surgery and biopsy samples.
· Liquid biopsy test allows early tumor recurrence detection.
Stage of Development:
Prototype available for demonstration
IPs:
Other

Partner sought

Type and Role of Partner Sought:
The Centre is interested to find foreign experts in medical examination and diagnostic companies that perform both laboratory services and cancer examinations.
Type of partner:
-SMEs, large enterprises from the medical examination and diagnostic companies that perform both laboratory services and cancer examinations field.
Role of partner
-Under the license agreement it will provide the manual of tests to sell the product and provide services related to the use of the test.

Client

Type and Size of Client:
R&D Institution
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
English
Latvian
Russian

Keywords

Technology Keywords:
06001003 Citología, cancerología, oncología